Biotech · Private company
Catalyst Biosciences
Track this companyFree. Adds Catalyst Biosciences to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- MarzAAPhase 3 · Hemophilia A With InhibitorClinicalTrials.gov · fetched Nov 12, 2026
- Coagulation Factor VIIa variantPhase 2 · Factor VII DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Natural History ObservationRecurrent Bacterial Infection, Autoimmune DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated DiseaseTERMINATED · started Aug 31, 2021ClinicalTrials.gov NCT05095623 · fetched Nov 12, 2026
- Screening Study to Identify Patients With Complement Factor I DeficienciesTERMINATED · started Jul 21, 2021ClinicalTrials.gov NCT05072912 · fetched Nov 12, 2026
- Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding DisordersPHASE1_PHASE2 · TERMINATED · started May 17, 2021ClinicalTrials.gov NCT04548791 · fetched Nov 12, 2026
- Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or BPHASE3 · TERMINATED · started May 4, 2021ClinicalTrials.gov NCT04489537 · fetched Nov 12, 2026